CLINICAL GENOMIC OPERATING SYSTEM
For Health Providers
StoreGene’s Clinical Genomic Operating System makes it faster, cheaper and easier to apply whole genome data into actionable clinical insights
Rapid Turnaround Time
From sample extraction to analysis and finished report, our Whole Genome Sequencing process can be carried out in just 30 days. For reanalysis, this is reduced to just 7 days.
Increased Diagnostic Yield
Over a large number of studies, the diagnostic yield attained by WES ranges between 25 and 50%, while the WGS diagnostic yield is about 40–60%.
Medication management
99.7% of people have a genetic variation which alters how they metabolise common medications. By using pharmacogenomic data you can reduce adverse drug reactions by 30%.
Targeted Genomic Analysis
We support the use of any virtual gene panel available on PanelApp, allowing clinically curated panels to be applied flexibly to existing or newly sequenced patients. Because analysis is performed on whole-genome data, panels can be run or re-run at any time without the need for additional sequencing, enabling you to adapt testing as clinical questions evolve or new evidence emerges.
VIRTUAL PANELS:
Targeted Genomic Analysis
We support the use of any virtual gene panel available on PanelApp, allowing clinically curated panels to be applied flexibly to existing or newly sequenced patients. Because analysis is performed on whole-genome data, panels can be run or re-run at any time without the need for additional sequencing, enabling you to adapt testing as clinical questions evolve or new evidence emerges.
VIRTUAL PANELS
Always Clinician-led
We believe that no individual should be presented with a genetic report without being provided with clinical guidance and context. Our reports are always shared with the clinician first, and released to the patient after consultation.
